/
Stock
/
/
APIChangelogInfoStock Talk

GALECTO

Trade GLTO
GLTO Insider Trades:
all
Created with Highcharts 10.1.0►►►►►►►►►►►►►►►►►►►►►►►►►►PriceVolumeJan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25-10001002003004005000500k1 000k1 500k2 000k2 500k3 000k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-07-03
2025-07-08
WINSLOW GARRETT
General Counsel
M - Exercise
Restricted Stock Units
-680
$0.00
1
$4.35M
2025-07-03
2025-07-08
WINSLOW GARRETT
General Counsel
M - Exercise
Common Stock
680
1
$4.35M
2025-07-03
2025-07-08
FIRMANI LORI
Interim CFO
S - Sale
Common Stock
-147
$3.39
-498.33
1
$4.35M
2025-07-03
2025-07-08
SCHAMBYE HANS
Chief Executive Officer
S - Sale
Common Stock
-735
$3.38
-2,484.3
1
$4.35M
2025-07-03
2025-07-08
FIRMANI LORI
Interim CFO
M - Exercise
Common Stock
374
1
$4.35M
2025-07-03
2025-07-08
WINSLOW GARRETT
General Counsel
S - Sale
Common Stock
-260
$3.39
-881.4
1
$4.35M
2025-07-03
2025-07-08
SCHAMBYE HANS
Chief Executive Officer
M - Exercise
Restricted Stock Units
-1,360
$0.00
1
$4.35M
2025-07-03
2025-07-08
SCHAMBYE HANS
Chief Executive Officer
M - Exercise
Common Stock
1,360
1
$4.35M
2025-07-03
2025-07-08
FIRMANI LORI
Interim CFO
M - Exercise
Restricted Stock Units
-374
$0.00
1
$4.35M
2025-06-18
2025-06-20
DALLAS JAYSON DONALD ALEXANDER
A - Grant
Stock Option (right to buy)
720
$0.00
1
$4.35M
2025-06-18
2025-06-20
GOLDFISCHER CARL
A - Grant
Stock Option (right to buy)
1,440
$0.00
1
$4.35M
2025-06-18
2025-06-20
DALLAS JAYSON DONALD ALEXANDER
A - Grant
Stock Option (right to buy)
720
$0.00
1
$4.35M
2025-06-18
2025-06-20
MUNSHI AMIT
A - Grant
Stock Option (right to buy)
720
$0.00
1
$4.35M
2025-06-18
2025-06-20
GOLDFISCHER CARL
A - Grant
Stock Option (right to buy)
1,440
$0.00
1
$4.35M
2025-06-18
2025-06-20
MUNSHI AMIT
A - Grant
Stock Option (right to buy)
720
$0.00
1
$4.35M
2025-06-18
2025-06-20
PRENER ANNE
A - Grant
Stock Option (right to buy)
720
$0.00
1
$4.35M
2025-06-18
2025-06-20
SHAPIRO DAVID
A - Grant
Stock Option (right to buy)
720
$0.00
1
$4.35M
2025-06-18
2025-06-20
WECHSLER AMY
A - Grant
Stock Option (right to buy)
720
$0.00
1
$4.35M
2025-06-18
2025-06-20
PRENER ANNE
A - Grant
Stock Option (right to buy)
720
$0.00
1
$4.35M
2025-06-18
2025-06-20
SHAPIRO DAVID
A - Grant
Stock Option (right to buy)
720
$0.00
1
$4.35M
2025-06-18
2025-06-20
WECHSLER AMY
A - Grant
Stock Option (right to buy)
720
$0.00
1
$4.35M
2025-01-03
2025-01-07
KRONMILLER MATTHEW
EVP Strategy and CBO
A - Grant
Stock Option (right to buy)
6,000
$0.00
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
A - Grant
Stock Option (right to buy)
16,400
$0.00
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
A - Grant
Stock Option (right to buy)
6,000
$0.00
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
M - Exercise
Common Stock
2,640
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
M - Exercise
Restricted Stock Units
-1,320
$0.00
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
M - Exercise
Common Stock
1,320
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
S - Sale
Common Stock
-261
$6.00
-1,566
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
S - Sale
Common Stock
-1,341
$6.00
-8,046
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
S - Sale
Common Stock
-471
$6.00
-2,826
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
M - Exercise
Restricted Stock Units
-2,640
$0.00
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
M - Exercise
Common Stock
2,640
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
M - Exercise
Restricted Stock Units
-1,320
$0.00
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
M - Exercise
Common Stock
1,320
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
S - Sale
Common Stock
-261
$6.00
-1,566
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
A - Grant
Stock Option (right to buy)
5,000
$0.00
1
$4.35M
2025-01-03
2025-01-07
KRONMILLER MATTHEW
EVP Strategy and CBO
A - Grant
Stock Option (right to buy)
6,000
$0.00
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
A - Grant
Stock Option (right to buy)
16,400
$0.00
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
M - Exercise
Restricted Stock Units
-726
$0.00
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
M - Exercise
Common Stock
726
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
M - Exercise
Common Stock
2,640
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
M - Exercise
Restricted Stock Units
-1,320
$0.00
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
M - Exercise
Common Stock
1,320
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
S - Sale
Common Stock
-261
$6.00
-1,566
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
S - Sale
Common Stock
-1,341
$6.00
-8,046
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
S - Sale
Common Stock
-471
$6.00
-2,826
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
M - Exercise
Restricted Stock Units
-726
$0.00
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
M - Exercise
Common Stock
726
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
M - Exercise
Restricted Stock Units
-726
$0.00
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
M - Exercise
Common Stock
726
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
S - Sale
Common Stock
-1,341
$6.00
-8,046
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
S - Sale
Common Stock
-471
$6.00
-2,826
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
M - Exercise
Restricted Stock Units
-2,640
$0.00
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
A - Grant
Stock Option (right to buy)
5,000
$0.00
1
$4.35M
2025-01-03
2025-01-07
KRONMILLER MATTHEW
EVP Strategy and CBO
A - Grant
Stock Option (right to buy)
6,000
$0.00
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
A - Grant
Stock Option (right to buy)
16,400
$0.00
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
A - Grant
Stock Option (right to buy)
6,000
$0.00
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
A - Grant
Stock Option (right to buy)
5,000
$0.00
1
$4.35M
2025-01-03
2025-01-07
KRONMILLER MATTHEW
EVP Strategy and CBO
A - Grant
Stock Option (right to buy)
6,000
$0.00
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
A - Grant
Stock Option (right to buy)
16,400
$0.00
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
A - Grant
Stock Option (right to buy)
6,000
$0.00
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
M - Exercise
Restricted Stock Units
-2,640
$0.00
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
A - Grant
Stock Option (right to buy)
6,000
$0.00
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
M - Exercise
Restricted Stock Units
-726
$0.00
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
M - Exercise
Common Stock
726
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
M - Exercise
Restricted Stock Units
-2,640
$0.00
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
M - Exercise
Common Stock
2,640
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
M - Exercise
Restricted Stock Units
-1,320
$0.00
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
M - Exercise
Common Stock
1,320
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
S - Sale
Common Stock
-261
$6.00
-1,566
1
$4.35M
2025-01-03
2025-01-07
SCHAMBYE HANS
Chief Executive Officer
S - Sale
Common Stock
-1,341
$6.00
-8,046
1
$4.35M
2025-01-03
2025-01-07
WINSLOW GARRETT
General Counsel
S - Sale
Common Stock
-471
$6.00
-2,826
1
$4.35M
2025-01-03
2025-01-07
FIRMANI LORI
Interim CFO
A - Grant
Stock Option (right to buy)
5,000
$0.00
1
$4.35M
2024-10-11
2024-10-15
WECHSLER AMY
A - Grant
Stock Option (right to buy)
1,200
$0.00
2
$4.35M
2024-10-09
2024-10-11
KRONMILLER MATTHEW
EVP Strategy and CBO
A - Grant
Stock Option (right to buy)
8,600
$0.00
1
$4.35M
2024-10-09
2024-10-11
SCHAMBYE HANS
Chief Executive Officer
A - Grant
Stock Option (right to buy)
44,100
$0.00
1
$4.35M
2024-10-09
2024-10-11
FIRMANI LORI
Interim CFO
A - Grant
Stock Option (right to buy)
13,000
$0.00
1
$4.35M
2024-10-09
2024-10-11
WINSLOW GARRETT
General Counsel
A - Grant
Stock Option (right to buy)
15,600
$0.00
1
$4.35M
2024-06-20
2024-06-21
PRENER ANNE
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2024-06-20
2024-06-21
DALLAS JAYSON DONALD ALEXANDER
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2024-06-20
2024-06-21
GOLDFISCHER CARL
A - Grant
Stock Option (right to buy)
36,000
$0.00
1
$4.35M
2024-06-20
2024-06-21
MUNSHI AMIT
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2024-06-20
2024-06-21
SHAPIRO DAVID
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2024-01-03
2024-01-05
FREVE JONATHAN
Chief Financial Officer
A - Grant
Restricted Stock Units
100K
$0.00
1
$4.35M
2024-01-03
2024-01-05
SCHAMBYE HANS
Chief Executive Officer
A - Grant
Restricted Stock Units
200K
$0.00
1
$4.35M
2024-01-03
2024-01-05
WINSLOW GARRETT
General Counsel
A - Grant
Restricted Stock Units
100K
$0.00
1
$4.35M
2023-10-02
2023-10-02
THE BIOTECH GROWTH TRUST PLC
S - Sale
-57,312
$1.00
-57,312
1
$4.35M
2023-10-02
2023-10-02
ORBIMED GENESIS MASTER FUND, L.P.
S - Sale
-37,675
$1.00
-37,675
1
$4.35M
2023-10-02
2023-10-02
ORBIMED ISRAEL PARTNERS II, L.P.
S - Sale
-245K
$1.00
-245K
1
$4.35M
2023-10-02
2023-10-02
ORBIMED PRIVATE INVESTMENTS VII, LP
S - Sale
-585K
$1.00
-585K
1
$4.35M
2023-08-30
2023-08-30
ORBIMED ISRAEL PARTNERS II, L.P.
S - Sale
-511K
$1.00
-511K
1
$4.35M
2023-08-30
2023-08-30
ORBIMED GENESIS MASTER FUND, L.P.
S - Sale
-78,659
$1.00
-78,659
1
$4.35M
2023-08-30
2023-08-30
ORBIMED PRIVATE INVESTMENTS VII, LP
S - Sale
-1.22M
$1.00
-1.22M
1
$4.35M
2023-08-30
2023-08-30
THE BIOTECH GROWTH TRUST PLC
S - Sale
-120K
$1.00
-120K
1
$4.35M
2023-08-21
2023-08-21
ORBIMED GENESIS MASTER FUND, L.P.
S - Sale
-97,204
$1.00
-97,204
1
$4.35M
2023-08-21
2023-08-21
ORBIMED ISRAEL PARTNERS II, L.P.
S - Sale
-631K
$1.00
-631K
1
$4.35M
2023-08-21
2023-08-21
ORBIMED PRIVATE INVESTMENTS VII, LP
S - Sale
-1.51M
$1.00
-1.51M
1
$4.35M
2023-08-21
2023-08-21
THE BIOTECH GROWTH TRUST PLC
S - Sale
-148K
$1.00
-148K
1
$4.35M
2023-08-15
2023-08-21
ORBIMED GENESIS MASTER FUND, L.P.
S - Sale
-75,473
$1.00
-75,473
1
$4.35M
2023-08-15
2023-08-17
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-823K
$1.00
-823K
3
$4.35M
2023-08-15
2023-08-15
ORBIMED PRIVATE INVESTMENTS VII, LP
S - Sale
-1.17M
$1.00
-1.17M
1
$4.35M
2023-08-15
2023-08-15
ORBIMED GENESIS MASTER FUND, L.P.
S - Sale
-75,473
$1.00
-75,473
1
$4.35M
2023-08-15
2023-08-15
ORBIMED ISRAEL PARTNERS II, L.P.
S - Sale
-490K
$1.00
-490K
1
$4.35M
2023-08-15
2023-08-15
THE BIOTECH GROWTH TRUST PLC
S - Sale
-115K
$1.00
-115K
1
$4.35M
2023-07-31
2023-08-02
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-209K
$3.00
-628K
3
$4.35M
2023-07-31
2023-07-31
ORBIMED GENESIS MASTER FUND, L.P.
S - Sale
-162K
$3.00
-486K
1
$4.35M
2023-07-31
2023-07-31
ORBIMED ISRAEL PARTNERS II, L.P.
S - Sale
-180K
$3.00
-541K
1
$4.35M
2023-07-31
2023-07-31
ORBIMED PRIVATE INVESTMENTS VII, LP
S - Sale
-931K
$3.00
-2.79M
1
$4.35M
2023-07-31
2023-07-31
THE BIOTECH GROWTH TRUST PLC
S - Sale
-247K
$3.00
-740K
1
$4.35M
2023-07-25
2023-07-27
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-39,200
$3.00
-118K
3
$4.35M
2023-07-25
2023-07-25
THE BIOTECH GROWTH TRUST PLC
S - Sale
-8,100
$2.00
-16,200
1
$4.35M
2023-07-25
2023-07-25
ORBIMED GENESIS MASTER FUND, L.P.
S - Sale
-7,800
$2.00
-15,600
1
$4.35M
2023-07-25
2023-07-25
ORBIMED ISRAEL PARTNERS II, L.P.
S - Sale
-4,700
$2.00
-9,400
1
$4.35M
2023-07-25
2023-07-25
ORBIMED PRIVATE INVESTMENTS VII, LP
S - Sale
-26,700
$2.00
-53,400
1
$4.35M
2023-07-13
2023-07-17
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-195K
$2.00
-389K
3
$4.35M
2023-07-13
2023-07-13
ORBIMED GENESIS MASTER FUND, L.P.
S - Sale
-9,800
$3.00
-29,400
1
$4.35M
2023-07-13
2023-07-13
ORBIMED ISRAEL PARTNERS II, L.P.
S - Sale
-52,800
$3.00
-158K
1
$4.35M
2023-07-13
2023-07-13
ORBIMED PRIVATE INVESTMENTS VII, LP
S - Sale
-132K
$3.00
-396K
1
$4.35M
2023-07-13
2023-07-13
THE BIOTECH GROWTH TRUST PLC
S - Sale
-14,700
$3.00
-44,100
1
$4.35M
2023-06-17
2023-06-15
DALLAS JAYSON DONALD ALEXANDER
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2023-06-14
2023-06-15
MUNSHI AMIT
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2023-06-14
2023-06-15
GOLDFISCHER CARL
A - Grant
Stock Option (right to buy)
36,000
$0.00
1
$4.35M
2023-06-14
2023-06-15
PRENER ANNE
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2023-06-14
2023-06-15
SHAPIRO DAVID
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2023-06-14
2023-06-15
KHUONG CHAU QUANG
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2023-04-17
2023-04-17
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-13,089
$2.00
-26,178
3
$4.35M
2023-04-14
2023-04-17
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-41,446
$2.00
-82,892
3
$4.35M
2023-04-13
2023-04-17
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-13,946
$2.00
-27,892
3
$4.35M
2023-04-12
2023-04-12
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-2,363
$2.00
-4,726
3
$4.35M
2023-04-11
2023-04-12
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-13,946
$2.00
-27,892
3
$4.35M
2023-04-10
2023-04-12
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-51,228
$2.00
-102K
3
$4.35M
2023-04-10
2023-04-10
ORBIMED ISRAEL PARTNERS II, L.P.
S - Sale
-9,064
$2.00
-18,128
1
$4.35M
2023-04-10
2023-04-10
THE BIOTECH GROWTH TRUST PLC
S - Sale
-2,512
$2.00
-5,024
1
$4.35M
2023-04-10
2023-04-10
ORBIMED GENESIS MASTER FUND, L.P.
S - Sale
-1,686
$2.00
-3,372
1
$4.35M
2023-04-10
2023-04-10
ORBIMED PRIVATE INVESTMENTS VII, LP
S - Sale
-22,638
$2.00
-45,276
1
$4.35M
2023-04-06
2023-04-07
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-9,665
$2.00
-19,330
3
$4.35M
2023-04-05
2023-04-07
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-92,965
$2.00
-186K
3
$4.35M
2023-04-05
2023-04-05
ORBIMED GENESIS MASTER FUND, L.P.
S - Sale
-8,143
$2.00
-16,286
1
$4.35M
2023-04-05
2023-04-05
ORBIMED ISRAEL PARTNERS II, L.P.
S - Sale
-43,810
$2.00
-87,620
1
$4.35M
2023-04-05
2023-04-05
ORBIMED PRIVATE INVESTMENTS VII, LP
S - Sale
-110K
$2.00
-219K
1
$4.35M
2023-04-05
2023-04-05
THE BIOTECH GROWTH TRUST PLC
S - Sale
-12,215
$2.00
-24,430
1
$4.35M
2023-01-04
2023-01-05
LINDMARK BERTIL
Chief Medical Officer
A - Grant
Stock Option (right to buy)
115K
$0.00
1
$4.35M
2023-01-04
2023-01-05
FREVE JONATHAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
115K
$0.00
1
$4.35M
2023-01-04
2023-01-05
OESTREICH STEPHANIE
Chief Business Officer
A - Grant
Stock Option (right to buy)
80,000
$0.00
1
$4.35M
2023-01-04
2023-01-05
PEDERSEN ANDERS
Chief Operating Officer
A - Grant
Stock Option (right to buy)
115K
$0.00
1
$4.35M
2023-01-04
2023-01-05
SCHAMBYE HANS
Chief Executive Officer
A - Grant
Stock Option (right to buy)
300K
$0.00
1
$4.35M
2023-01-04
2023-01-05
WINSLOW GARRETT
General Counsel
A - Grant
Stock Option (right to buy)
80,000
$0.00
1
$4.35M
2022-06-14
2022-06-15
KHUONG CHAU QUANG
A - Grant
/s/ Jonathan Freve, attorney-in-fact
18,000
$0.00
1
$4.35M
2022-06-14
2022-06-15
MUNSHI AMIT
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2022-06-14
2022-06-15
PRENER ANNE
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2022-06-14
2022-06-15
SHAPIRO DAVID
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2022-06-14
2022-06-15
DALLAS JAYSON DONALD ALEXANDER
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2022-06-14
2022-06-15
GOLDFISCHER CARL
A - Grant
Stock Option (right to buy)
36,000
$0.00
1
$4.35M
2022-03-22
2022-03-23
LINDMARK BERTIL
Chief Medical Officer
P - Purchase
Common Stock
14,604
$2.00
29,208
1
$4.35M
2022-03-22
2022-03-23
SCHAMBYE HANS
Chief Executive Officer
P - Purchase
Common Stock
5,000
$2.00
10,000
1
$4.35M
2022-02-15
2022-02-15
OESTREICH STEPHANIE
Chief Business Officer
A - Grant
Stock Option (right to buy)
140K
$0.00
1
$4.35M
2022-01-04
2022-01-06
FREVE JONATHAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
119K
$0.00
1
$4.35M
2022-01-04
2022-01-06
LINDMARK BERTIL
Chief Medical Officer
A - Grant
Stock Option (right to buy)
119K
$0.00
1
$4.35M
2022-01-04
2022-01-06
PEDERSEN ANDERS
Chief Operating Officer
A - Grant
Stock Option (right to buy)
119K
$0.00
1
$4.35M
2022-01-04
2022-01-06
SCHAMBYE HANS
Chief Executive Officer
A - Grant
Stock Option (right to buy)
288K
$0.00
1
$4.35M
2022-01-04
2022-01-06
WINSLOW GARRETT
General Counsel
A - Grant
Stock Option (right to buy)
75,000
$0.00
1
$4.35M
2021-12-03
2021-12-06
FREVE JONATHAN
Chief Financial Officer
P - Purchase
Common Stock
4,000
$2.00
8,000
1
$4.35M
2021-12-03
2021-12-06
WINSLOW GARRETT
General Counsel
P - Purchase
Common Stock
2,000
$2.00
4,000
1
$4.35M
2021-11-17
2021-11-19
GOLDFISCHER CARL
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2021-11-17
2021-11-19
KHUONG CHAU QUANG
A - Grant
Stock Option (right to buy)
9,000
$0.00
1
$4.35M
2021-11-09
2021-11-10
SCHAMBYE HANS
Chief Executive Officer
P - Purchase
Common Stock
4,500
$4.00
18,000
1
$4.35M
2021-11-08
2021-11-09
FREVE JONATHAN
Chief Financial Officer
P - Purchase
Common Stock
3,000
$3.00
9,000
1
$4.35M
2021-08-18
2021-08-19
FREVE JONATHAN
Chief Financial Officer
P - Purchase
Common Stock
3,000
$4.00
12,000
1
$4.35M
2021-06-28
2021-06-28
LINDMARK BERTIL
Chief Medical Officer
P - Purchase
Common Stock
2,000
$5.00
10,000
1
$4.35M
2021-06-24
2021-06-24
SCHAMBYE HANS
Chief Executive Officer
P - Purchase
Common Stock
3,000
$5.00
15,000
1
$4.35M
2021-06-23
2021-06-23
FREVE JONATHAN
Chief Financial Officer
P - Purchase
Common Stock
2,000
$5.00
10,000
1
$4.35M
2021-06-23
2021-06-23
WINSLOW GARRETT
General Counsel
P - Purchase
Common Stock
2,000
$5.00
10,000
1
$4.35M
2021-06-15
2021-06-16
WINSLOW GARRETT
General Counsel
A - Grant
Stock Option (right to buy)
120K
$0.00
1
$4.35M
2021-05-26
2021-05-28
DALLAS JAYSON DONALD ALEXANDER
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2021-05-26
2021-05-28
GOLDFISCHER CARL
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2021-05-26
2021-05-28
KHUONG CHAU QUANG
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2021-05-26
2021-05-28
PRENER ANNE
A - Grant
Stock Option (right to buy)
18,000
$0.00
1
$4.35M
2021-01-08
2021-01-08
PRENER ANNE
A - Grant
Stock Option (right to buy)
24,000
$0.00
2
$4.35M
2021-01-05
2021-01-07
FREVE JONATHAN
Chief Financial Officer
A - Grant
Stock Option (right to buy)
95,000
$0.00
1
$4.35M
2021-01-05
2021-01-07
LINDMARK BERTIL
Chief Medical Officer
A - Grant
Stock Option (right to buy)
95,000
$0.00
1
$4.35M
2021-01-05
2021-01-07
PEDERSEN ANDERS
Chief Operating Officer
A - Grant
Stock Option (right to buy)
100K
$0.00
1
$4.35M
2021-01-05
2021-01-07
SCHAMBYE HANS
Chief Executive Officer
A - Grant
Stock Option (right to buy)
230K
$0.00
1
$4.35M
2020-11-19
2020-11-23
DALLAS JAYSON DONALD ALEXANDER
A - Grant
Stock Option (right to buy)
27,000
$0.00
2
$4.35M
2020-11-02
2020-11-04
SCHAMBYE HANS
Chief Executive Officer
C - Conversion
Common Stock
13,931
1
$4.35M
2020-11-02
2020-11-04
NOVO HOLDINGS A/S
C - Conversion
SERIES C-2 PREFERRED STOCK
-195K
1
$4.35M
2020-11-02
2020-11-04
NOVO HOLDINGS A/S
C - Conversion
SERIES C-4 PREFERRED STOCK
-182K
1
$4.35M
2020-11-02
2020-11-04
ORBIMED ADVISORS LLC
C - Conversion
Series C-4 Preferred Stock
-382K
2
$4.35M
2020-11-02
2020-11-04
ORBIMED ADVISORS LLC
C - Conversion
Series C-5 Preferred Stock
-109K
2
$4.35M
2020-11-02
2020-11-04
ORBIMED ADVISORS LLC
C - Conversion
Series D Preferred Stock
-282K
3
$4.35M
2020-11-02
2020-11-04
ORBIMED ADVISORS LLC
C - Conversion
Common Shares
3.07M
3
$4.35M
2020-11-02
2020-11-04
PEDERSEN ANDERS
Chief Operating Officer
C - Conversion
Series C-1 Preferred Stock
-1,441
$0.00
1
$4.35M
2020-11-02
2020-11-04
PEDERSEN ANDERS
Chief Operating Officer
C - Conversion
Common Stock
3,746
1
$4.35M
2020-11-02
2020-11-04
SCHAMBYE HANS
Chief Executive Officer
C - Conversion
Series C-1 Preferred Stock
-5,359
$0.00
1
$4.35M
2020-11-02
2020-11-04
NOVO HOLDINGS A/S
C - Conversion
SERIES C-5 PREFERRED STOCK
-51,911
1
$4.35M
2020-11-02
2020-11-04
NOVO HOLDINGS A/S
C - Conversion
SERIES D PREFERRED STOCK
-98,930
1
$4.35M
2020-11-02
2020-11-04
NOVO HOLDINGS A/S
C - Conversion
COMMON STOCK
2.16M
1
$4.35M
2020-11-02
2020-11-04
ORBIMED ADVISORS LLC
C - Conversion
Series C-2 Preferred Stock
-409K
2
$4.35M
2020-11-02
2020-11-04
CHRISTGAU STEPHAN
P - Purchase
Common Stock
66,666
$15.00
1000K
1
$4.35M
2020-11-02
2020-11-04
KHUONG CHAU QUANG
P - Purchase
Common Shares
733K
$15.00
11M
2
$4.35M
2020-11-02
2020-11-04
NOVO HOLDINGS A/S
P - Purchase
COMMON STOCK
333K
$15.00
5.00M
1
$4.35M
2020-11-02
2020-11-04
ORBIMED ADVISORS LLC
P - Purchase
Common Shares
733K
$15.00
11M
2
$4.35M
2020-11-02
2020-11-04
CHRISTGAU STEPHAN
C - Conversion
Series D Preferred Stock
-184K
$0.00
1
$4.35M
2020-11-02
2020-11-04
CHRISTGAU STEPHAN
C - Conversion
Common Stock
479K
1
$4.35M
2020-11-02
2020-11-04
GOLDFISCHER CARL
C - Conversion
Series C-3 Preferred Stock
-400K
$0.00
2
$4.35M
2020-11-02
2020-11-04
GOLDFISCHER CARL
C - Conversion
Series D Preferred Stock
-3,688
$0.00
1
$4.35M
2020-11-02
2020-11-04
GOLDFISCHER CARL
C - Conversion
Common Stock
1.05M
3
$4.35M
2020-11-02
2020-11-04
KHUONG CHAU QUANG
C - Conversion
Series C-2 Preferred Stock
-409K
2
$4.35M
2020-11-02
2020-11-04
KHUONG CHAU QUANG
C - Conversion
Series C-4 Preferred Stock
-382K
2
$4.35M
2020-11-02
2020-11-04
KHUONG CHAU QUANG
C - Conversion
Series C-5 Preferred Stock
-109K
2
$4.35M
2020-11-02
2020-11-04
KHUONG CHAU QUANG
C - Conversion
Series D Preferred Stock
-282K
3
$4.35M
2020-11-02
2020-11-04
KHUONG CHAU QUANG
C - Conversion
Common Shares
3.07M
3
$4.35M
2020-11-02
2020-11-04
MUNSHI AMIT
C - Conversion
Series D Preferred Stock
-1,844
$0.00
1
$4.35M
2020-11-02
2020-11-04
MUNSHI AMIT
C - Conversion
Common Stock
4,793
1
$4.35M
2020-11-02
2020-11-04
NOVO HOLDINGS A/S
C - Conversion
SERIES B-1 PREFERRED STOCK
-25,562
1
$4.35M
2020-11-02
2020-11-04
NOVO HOLDINGS A/S
C - Conversion
SERIES B-2 PREFERRED STOCK
-15,833
1
$4.35M
2020-11-02
2020-11-04
NOVO HOLDINGS A/S
C - Conversion
SERIES B-3 PREFERRED STOCK
-63,333
1
$4.35M
2020-11-02
2020-11-04
NOVO HOLDINGS A/S
C - Conversion
SERIES B-4 PREFERRED STOCK
-66,666
1
$4.35M
2020-11-02
2020-11-04
NOVO HOLDINGS A/S
C - Conversion
SERIES C-1 PREFERRED STOCK
-134K
1
$4.35M
2020-10-07
2020-11-04
PEDERSEN ANDERS
Chief Operating Officer
A - Grant
Stock Option (right to buy)
77,991
$0.00
1
$4.35M
2020-10-07
2020-11-04
SCHAMBYE HANS
Chief Executive Officer
A - Grant
Stock Option (right to buy)
520K
$0.00
1
$4.35M
2020-09-25
2020-11-04
KHUONG CHAU QUANG
A - Grant
Series D Preferred Stock
-282K
$27.00
-7.60M
3
$4.35M
2020-09-25
2020-11-04
MUNSHI AMIT
A - Grant
Series D Preferred Stock
1,844
$27.00
49,788
1
$4.35M
2020-09-25
2020-11-04
ORBIMED ADVISORS LLC
A - Grant
Series D Preferred Stock
-282K
$27.00
-7.60M
3
$4.35M
2020-09-25
2020-11-04
GOLDFISCHER CARL
A - Grant
Series D Preferred Stock
3,688
$27.00
99,576
1
$4.35M
2020-06-24
2020-11-04
PEDERSEN ANDERS
Chief Operating Officer
A - Grant
Stock Option (right to buy)
143K
$0.00
1
$4.35M
2020-06-24
2020-11-04
MUNSHI AMIT
A - Grant
Stock Option (right to buy)
109K
$0.00
1
$4.35M
2020-06-24
2020-11-04
SCHAMBYE HANS
Chief Executive Officer
A - Grant
Stock Option (right to buy)
208K
$0.00
1
$4.35M